Monoclonal Antibodies Against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine

Monoclonal Antibodies Against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine
Title:
Monoclonal Antibodies Against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine
Other Titles:
Cell Reports
Publication Date:
02 January 2018
Citation:
Cell Reports, Volume 22, Issue 1, 299 - 312
Abstract:
The large number of mutations identified across all cancers represents an untapped reservoir of targets that can be useful for therapeutic targeting if highly selective, mutation-specific reagents are available. We report here our attempt to generate such reagents: monoclonal antibodies against the most common R175H, R248Q, and R273H hotspot mutants of the tumor suppressor p53. These antibodies recognize their intended specific alterations without any cross-reactivity against wild-type (WT) p53 or other p53 mutants, including at the same position (as exemplified by anti-R248Q antibody, which does not recognize the R248W mutation), evaluated by direct immunoblotting, immunoprecipitation, and immunofluorescence methods on transfected and endogenous proteins. Moreover, their clinical utility to diagnose the presence of specific p53 mutants in human tumor microarrays by immunohistochemistry is also shown. Together, the data demonstrate that antibodies against specific single-amino-acid alterations can be generated reproducibly and highlight their utility, which could potentially be extended to therapeutic settings.
License type:
http://creativecommons.org/licenses/by-nc-nd/4.0/
Funding Info:
Description:
ISSN:
2211-1247
Collections:
Files uploaded: